{"filing":{"accession_number":"0001493152-26-035762","cik":"0001535955","ticker":"LPCN","company_name":"Lipocine Inc.","form":"8-K","filing_date":"2026-08-03","report_date":"2026-08-03","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226035762/form8-k.htm"},"events":[{"id":23415,"run_id":21168,"accession_number":"0001493152-26-035762","anchor_item_number":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of Michael J. Grissinger as a director of Lipocine Inc., effective August 3, 2026. Item 5.02 explicitly states the Board expanded to five members and appointed Mr. Grissinger as a director, with details on his compensation (2,000 share option grant and $55,000 annual retainer). The press release emphasizes his extensive pharmaceutical and M\u0026A experience from Johnson \u0026 Johnson, positioning him as a valuable addition to advance the company's pipeline and partnerships. This is a material governance event affecting board composition.","company_name":"Lipocine Inc.","ticker":"LPCN","filing_date":"2026-08-03","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":23632,"accession_number":"0001493152-26-035762","item_number":null,"item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Michael J. Grissinger as a director of Lipocine Inc., effective August 3, 2026. Item 5.02 explicitly states the Board expanded to five members and appointed Mr. Grissinger as a director, with details on his compensation (2,000 share option grant and $55,000 annual retainer). The press release emphasizes his extensive pharmaceutical and M\u0026A experience from Johnson \u0026 Johnson, positioning him as a valuable addition to advance the company's pipeline and partnerships. This is a material governance event affecting board composition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:26:55.842414+00:00","company_name":"Lipocine Inc.","ticker":"LPCN","filing_date":"2026-08-03"}]}